China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients lose weight while preserving muscle, the biotech said on Wednesday. WHY IT MATTERS Lilly is aiming to strengthen its position as a leader in the obesity treatment market,
Posted by Hicham ALAOUI RIZQ on 2024, Nov 20
Introduction
Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients lose weight while preserving muscle, the biotech said on Wednesday. WHY IT MATTERS Lilly is aiming to strengthen its position as a leader in the obesity treatment market,
Article Link
Read more: China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug